One Year Follow-Up in a Phase ½ Clinical Trial of a Gene Modifier Therapy (OCU400) for the Treatment of Retinitis Pigmentosa

  • Benjamin Bakall, MD, PhD
  • Video
  • Published 2024

Related

See more